Drugs Archives - Page 28 of 66 - ��ýҕ�l Health News

KHN’s ‘What the Health?’: ACA Packs More Benefits — And More Confusion

The covid relief bill signed by President Joe Biden includes a long list of new health benefits for consumers. But many eligible people may have difficulty taking advantage of them because of the interaction with the income tax system and a lack of expert guidance. Meanwhile, Democrats are debating internally about what should come next on the health agenda. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more.

March 18, 2021

POSTCARD FROM LONG BEACH

‘Super-Sized’ Vaccine Clinic Offers Food Workers Some Relief

Long Beach, which has its own health department, kicked off a vaccination campaign for essential workers by inviting 3,000 food workers to a splashy vaccination event at the city’s convention center.

By Lori Basheda

March 18, 2021

Newborn baby gripping their mother's hand

Doctors Debate Use of Blood Thinners to Prevent Clots in Women After C-Sections

One group of maternal health experts in 2016 urged doctors to give all women heparin shots after C-sections, barring specific medical risks for individual patients. But many physicians disagree, questioning whether wide use of the drug is effective, worth the cost and safe, since it carries the risk of bleeding.

By Harris Meyer

March 17, 2021

COVID-19

High Obesity Rates in Southern States Magnify Covid Threat

In the American South — home to nine of the nation’s 12 heaviest states — obesity is playing a role not only in covid outcomes, but in the calculus of the vaccination rollout.

By Sarah Varney

March 11, 2021

COVID-19

Pfizer’s Newest Vaccine Plant Has Persistent Mold Issues, History of Recalls

After nearly a decade’s worth of federal inspections, reprimands and corrective action plans, has Pfizer fixed the facility that will be filling vials of its covid vaccine?

By Sarah Jane Tribble

March 10, 2021

Podcast

KHN’s ‘What the Health?’: Good and Not-So-Good News on Covid

The FDA authorized the emergency use of a one-shot vaccine made by Johnson & Johnson, which could help accelerate the pace of vaccinations to prevent covid-19. But after a dramatic decline, case numbers are again rising, and several states are rolling back public health mitigation efforts. Mary Ellen McIntire of CQ Roll Call, Joanne Kenen of Politico and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Jordan Rau about the latest KHN-NPR “Bill of the Month” episode.

March 4, 2021

Beth Ann Wilmore checks a vaccine vial at her community health center

COVID-19

Accidentally Trashed, Thawed or Expired: Reports of Covid Vaccine Spoilage

As the speed of covid vaccinations picks up, so do the reports of doses going to waste. Health officials are trying to rein in waste without slowing down vaccinations.

By Blake Farmer, Nashville Public Radio

March 4, 2021

COVID-19

In California, Caregivers of People With Disabilities Are Being Turned Away at COVID Vaccine Sites

Parents and caregivers of people with disabilities in California are supposed to be near the front of the line for the covid-19 vaccine. But some are hitting roadblocks at vaccination sites.

By Jackie Fortiér, LAist

March 3, 2021

COVID-19

Why AstraZeneca and J&J’s Vaccines, In Use Elsewhere, Are Still on Hold in America

Covid has pressed the Food and Drug Administration into its fastest vaccine reviews ever — which are still painfully slow, critics say.

By Sarah Jane Tribble

Feb. 26, 2021

COVID-19

After Billions of Dollars and Dozens of Wartime Declarations, Why Are Vaccines Still in Short Supply?

The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfangled vaccines have required herculean logistical efforts.

By Rachana Pradhan and Arthur Allen

Feb. 23, 2021

Podcast

KHN’s ‘What the Health?’: Open Enrollment, One More Time

Keeping a campaign promise, President Joe Biden has reopened enrollment for health coverage under the Affordable Care Act on healthcare.gov — and states that run their own health insurance marketplaces followed suit. At the same time, the Biden administration is moving to revoke the Trump administration’s permission for states to impose work requirements for some adults on the Medicaid health insurance program. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews medical student Inam Sakinah, president of the new group Future Doctors in Politics.

Feb. 18, 2021

KHN & PolitiFact HealthCheck

Can Pfizer and Moderna End the Pandemic by Sharing Their Vaccine Designs? It’s Not that Simple

Industry experts say it’s highly unlikely that dozens of pharmaceutical companies that aren’t already producing covid vaccines stand ready to do so.

By Samantha Putterman, PolitiFact

Feb. 15, 2021

As Drug Prices Keep Rising, State Lawmakers Propose Tough New Bills to Curb Them

The measures would impose taxes on increases in the price of drugs that don’t reflect improved clinical value and set the rates paid by state-run and commercial health plans to a benchmark based on prices in Canada.

By Harris Meyer

Feb. 12, 2021

Postcard from North Carolina

Farmworker Camps to Urban Tent Cities: Tailoring Vaccine Info to Where It’s Most Needed

Concerns arising in western North Carolina provide a window into the challenges facing health workers across the country as they seek to persuade vulnerable populations to be inoculated against covid.

By Aneri Pattani

Feb. 10, 2021

Podcast

KHN’s ‘What the Health?’: Covid and Kids

Can schools safely reopen before all teachers and staffers are vaccinated against covid? And what’s the best way to communicate that science — and scientific recommendations — change and evolve? Also, get ready for a redo of open enrollment for Affordable Care Act coverage, this time with help and outreach to find those eligible. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more.

Feb. 4, 2021

COVID-19

100 Million Covid Shots in 100 Days Doesn’t Get Us Back to Normal

President Joe Biden’s promise to reach this milestone is an important step forward in vaccine rollout. But it is only the beginning of the sweeping vaccination effort required.

By Victoria Knight

Feb. 3, 2021

COVID-19

When Your Chance for a Covid Shot Comes, Don’t Worry About the Numbers

The Johnson & Johnson vaccine that the FDA cleared Saturday was 66% effective overall in preventing moderate to severe covid, while the Pfizer and Moderna vaccines were more than 90% effective. But the numbers aren’t exactly comparable. And all three shots prevent hospitalization and death.

By Arthur Allen and Liz Szabo

Feb. 1, 2021

States Move Ahead With Canada Drug Importation While Awaiting Signal From Biden

As president, Donald Trump encouraged states to bring in drugs from Canada, where prices are cheaper. It’s not clear if the new administration will follow suit.

By Phil Galewitz

Jan. 29, 2021

Podcast

KHN’s ‘What the Health?’: The Long Road to Unwinding Trump Health Policies

President Joe Biden signed a pair of health-related executive orders this week that would, among other things, reopen enrollment under the Affordable Care Act and start to reverse former President Donald Trump’s anti-abortion policies. Meanwhile, Congress remains bogged down with taking up the next round of covid-19 relief. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health policy stories of the week they think you should read, too.

Jan. 28, 2021

COVID-19

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

With U.S. cases skyrocketing, demand for Gilead’s dark horse antiviral is only growing. Biden appointees propose potential legal tactics to tamp down the price for patients.

By Sarah Jane Tribble

Jan. 27, 2021

��ýҕ�l

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs